Trial Profile
Long-Term Treatment of Collagenous Colitis With Budesonide. Prospective, Doubleblind Placebo-Controlled Trial.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 16 Jan 2017
Price :
$35
*
At a glance
- Drugs Budesonide (Primary)
- Indications Microscopic colitis
- Focus Therapeutic Use
- 16 Jan 2017 New trial record